{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:05:48Z","timestamp":1792605948505,"version":"4.5.0"},"reference-count":150,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T00:00:00Z","timestamp":1485648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The term \u201caristolochic acid nephropathy\u201d (AAN) is used to include any form of toxic interstitial nephropathy that is caused either by ingestion of plants containing aristolochic acids (AA) as part of traditional phytotherapies (formerly known as \u201cChinese herbs nephropathy\u201d), or by the environmental contaminants in food (Balkan endemic nephropathy). It is frequently associated with urothelial malignancies. Although products containing AA have been banned in most of countries, AAN cases remain regularly reported all over the world. Moreover, AAN incidence is probably highly underestimated given the presence of AA in traditional herbal remedies worldwide and the weak awareness of the disease. During these two past decades, animal models for AAN have been developed to investigate underlying molecular and cellular mechanisms involved in AAN pathogenesis. Indeed, a more-in-depth understanding of these processes is essential to develop therapeutic strategies aimed to reduce the global and underestimated burden of this disease. In this regard, our purpose was to build a broad overview of what is currently known about AAN. To achieve this goal, we aimed to summarize the latest data available about underlying pathophysiological mechanisms leading to AAN development with a particular emphasis on the imbalance between vasoactive factors as well as a focus on the vascular events often not considered in AAN.<\/jats:p>","DOI":"10.3390\/ijms18020297","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T11:36:30Z","timestamp":1485776190000},"page":"297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":188,"title":["An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature"],"prefix":"10.3390","volume":"18","author":[{"given":"In\u00e8s","family":"Jadot","sequence":"first","affiliation":[{"name":"Molecular Physiology Research Unit\u2014URPhyM, Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Namur 5000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Emilie","family":"Decl\u00e8ves","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons 7000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Nortier","sequence":"additional","affiliation":[{"name":"Nephrology Department, Erasme Academic Hospital and Laboratory of Experimental Nephrology, Faculty of Medicine, Universit\u00e9 Libre de Bruxelles (ULB), Brussels 1070, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Caron","sequence":"additional","affiliation":[{"name":"Molecular Physiology Research Unit\u2014URPhyM, Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), Namur 5000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","article-title":"Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs","volume":"24","author":"Depierreux","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(94)90964-4","article-title":"Identification of aristolochic acid in Chinese herbs","volume":"343","author":"Vanhaelen","year":"1994","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(94)92786-3","article-title":"Urothelial malignancy in nephropathy due to Chinese herbs","volume":"344","author":"Cosyns","year":"1994","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb","volume":"342","author":"Nortier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_6","unstructured":"World Health Organization (2002). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Press."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: A worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1749-8546-3-13","article-title":"Prescription profile of potentially aristolochic acid containing Chinese herbal products: An analysis of National Health Insurance data in Taiwan between 1997 and 2003","volume":"3","author":"Hsieh","year":"2008","journal-title":"Chin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-1797.2008.01061.x","article-title":"Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid","volume":"14","author":"Lai","year":"2009","journal-title":"Nephrology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/ndt\/13.8.2115","article-title":"Interstitial renal fibrosis in a young woman: Association with a Chinese preparation given for irregular menses","volume":"13","author":"Ng","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/ki.1994.220","article-title":"Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?","volume":"45","author":"Cosyns","year":"1994","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ijc.10602","article-title":"Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?","volume":"101","author":"Arlt","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ijc.20316","article-title":"Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer","volume":"111","author":"Arlt","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nephro.2015.10.001","article-title":"N\u00e9phropathie aux acides aristolochiques (\u201cN\u00e9phropathie aux herbes chinoises\u201d)","volume":"11","author":"Nortier","year":"2015","journal-title":"N\u00e9phrol. Th\u00e9r."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00295084","article-title":"Acute toxicity of aristolochic acid in rodents","volume":"59","author":"Mengs","year":"1987","journal-title":"Arch. Toxicol."},{"key":"ref_17","first-page":"2025","article-title":"Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy","volume":"56","author":"Schmeiser","year":"1996","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/17.3.408","article-title":"Progression rate of Chinese herb nephropathy: Impact of Aristolochia fangchi ingested dose","volume":"17","author":"Martinez","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s002040050568","article-title":"Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats","volume":"72","author":"Cosyns","year":"1998","journal-title":"Arch. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1053\/ajkd.2001.28624","article-title":"Aristolochic acid nephropathy in a Chinese patient: Time to abandon the term \u201cChinese herbs nephropathy\u201d?","volume":"38","author":"Gillerot","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/acm.1998.4.1-9","article-title":"Misuse of Herbal Remedies: The case of an outbreak of terminal renal failure in Belgium (Chinese Herbs Nephropathy)","volume":"4","author":"Vanherweghem","year":"1998","journal-title":"J. Altern. Complement. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/ndt\/11.7.1359","article-title":"Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion","volume":"11","author":"Pena","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","first-page":"15","article-title":"End-Stage Renal Insufficiency Associated With Chinese Herbal Consumption in France","volume":"19","author":"Stengel","year":"1998","journal-title":"Nephrologie"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(99)03380-2","article-title":"Nephropathy caused by Chinese herbs in the UK","volume":"354","author":"Lord","year":"1999","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ndt\/16.2.400","article-title":"Reversible Fanconi syndrome after ingestion of a Chinese herbal \u201cremedy\u201d containing aristolochic acid","volume":"16","author":"Krumme","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_26","first-page":"334","article-title":"Chinese herb nephropathy","volume":"13","author":"Meyer","year":"2000","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5694\/j.1326-5377.2011.tb03011.x","article-title":"Nephropathy associated with use of a Chinese herbal product containing aristolochic acid","volume":"194","author":"Chau","year":"2011","journal-title":"Med. J. Aust."},{"key":"ref_28","first-page":"1101","article-title":"The clinical and pathological manifestations of aristolochic acid nephropathy\u2014The report of 58 cases","volume":"81","author":"Chen","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/ndt\/gfh159","article-title":"Aristolohic acid nephropathy complicating a patient with focal segmental glomerulosclerosis","volume":"19","author":"Lo","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ndt\/gfl556","article-title":"Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis","volume":"22","author":"Yang","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ndt\/gfr291","article-title":"Aristolochic acid nephropathy: Variation in presentation and prognosis","volume":"27","author":"Yang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0272-6386(00)70343-X","article-title":"Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs","volume":"35","author":"Yang","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/08860229909066988","article-title":"Renal tubular acidosis, hypokalemic paralysis, rhabdomyolysis, and acute renal failure\u2014A rare presentation of Chinese herbal nephropathy","volume":"21","author":"Lee","year":"1999","journal-title":"Ren. Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-006-0017-6","article-title":"Fanconi\u2019s syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs","volume":"21","author":"Hong","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"ref_35","first-page":"794","article-title":"Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function","volume":"39","author":"Tanaka","year":"1997","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"ref_36","first-page":"521116","article-title":"Aristolochic acid\u2014Induced Fanconi\u2019s syndrome and nephropathy presenting as hypokalemic paralysis","volume":"39","author":"Tanaka","year":"2000","journal-title":"Clin. Nephrol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10157-004-0296-9","article-title":"Adult onset Fanconi syndrome: Extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy","volume":"8","author":"Kazama","year":"2004","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jep.2013.06.028","article-title":"Is aristolochic acid nephropathy a widespread problem in developing countries: A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach","volume":"149","author":"Michl","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lee, S., Lee, T., Lee, B., Choi, H., Yang, M., Ihm, C., and Kim, M. (2004). Fanconi\u2019s syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology, 126\u2013129.","DOI":"10.1111\/j.1440-1797.2003.00232.x"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1561-5413(07)60003-9","article-title":"Aristolochic acid nephropathy: The Hong Kong perspective","volume":"9","author":"Poon","year":"2007","journal-title":"Hong Kong J. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/ndt\/gfm167","article-title":"For patients taking herbal therapy\u2014Lessons from aristolochic acid nephropathy","volume":"22","author":"Nortier","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jep.2009.05.028","article-title":"Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2\u2014A global assessment based on bibliographic sources","volume":"125","author":"Heinrich","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"ref_43","unstructured":"National Toxicology Program (2011). Aristolochic Acids. Rep. Carcinog., 12, 45\u201349."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s00204-016-1819-3","article-title":"Balkan endemic nephropathy: An update on its aetiology","volume":"90","author":"Arlt","year":"2016","journal-title":"Arch. Toxicol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ckj\/sft049","article-title":"Balkan endemic nephropathy\u2014Current status and future perspectives","volume":"6","year":"2013","journal-title":"Clin. Kidney J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.ki.5000231","article-title":"Fifty years of Balkan endemic nephropathy: Daunting questions, elusive answers","volume":"69","author":"Batuman","year":"2006","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000213081","article-title":"Fifty years of research in balkan endemic nephropathy: Where are we now?","volume":"112","year":"2009","journal-title":"Nephron Clin. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ki.5000120","article-title":"Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy","volume":"69","author":"Dimitrov","year":"2006","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10653-012-9477-8","article-title":"Possible health impacts of naturally occurring uptake of aristolochic acids by maize and cucumber roots: Links to the etiology of endemic (Balkan) nephropathy","volume":"35","author":"Pavlovic","year":"2013","journal-title":"Environ. Geochem. Health"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncpuro1019","article-title":"Balkan endemic nephropathy and associated urothelial cancer","volume":"5","author":"Stefanovic","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00508-005-0426-8","article-title":"Recent data on endemic nephropathy and related urothelial tumors in Croatia","volume":"117","author":"Domijan","year":"2005","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1681\/ASN.2007050537","article-title":"Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia","volume":"18","author":"Grollman","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.21756","article-title":"Aristolochic Acid Nephropathy: Harbinger of a Global Iatrogenic Disease","volume":"51","author":"Grollman","year":"2013","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/ndt\/gft384","article-title":"Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy","volume":"29","author":"Nortier","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid as a probable human cancer hazard in herbal remedies: A review","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"key":"ref_56","first-page":"116","article-title":"Endemic nephropathy: The case for chronic poisoning by Aristolochia","volume":"46","author":"Hranjec","year":"2005","journal-title":"Croat. Med. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.2011.428","article-title":"Chinese herbs nephropathy and Balkan endemic nephropathy: Toward a single entity, aristolochic acid nephropathy","volume":"81","year":"2012","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/carcin\/bgm082","article-title":"Aristolochic acid mutagenesis: Molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer","volume":"28","author":"Arlt","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1021\/tx3000889","article-title":"Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography\/ion-trap mass spectrometry","volume":"25","author":"Yun","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1021\/acs.jafc.6b02203","article-title":"Quantitation of Aristolochic Acids in Corn, Wheat Grain, and Soil Samples Collected in Serbia: Identifying a Novel Exposure Pathway in the Etiology of Balkan Endemic Nephropathy","volume":"64","author":"Chan","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/acs.jafc.5b05089","article-title":"Uptake and Accumulation of Nephrotoxic and Carcinogenic Aristolochic Acids in Food Crops Grown in Aristolochia clematitis-Contaminated Soil and Water","volume":"64","author":"Li","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","first-page":"301","article-title":"Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: Could different components of aristolochic acids cause a different type of Chinese herb nephropathy?","volume":"53","author":"Tanaka","year":"2000","journal-title":"Clin. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/12.1.81","article-title":"Chinese herbs nephropathy presentation, natural history and fate after transplantation","volume":"12","author":"Reginster","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/ki.1995.449","article-title":"Low molecular weight proteinuria in Chinese herbs nephropathy","volume":"48","author":"Kabanda","year":"1995","journal-title":"Kidney Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.1997.35","article-title":"Proximal tubular injury in Chinese herbs nephropathy: Monitoring by neutral endopeptidase enzymuria","volume":"51","author":"Nortier","year":"1997","journal-title":"Kidney Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(01)06576-X","article-title":"Urothelial malignant disease and Chinese herbal nephropathy","volume":"358","author":"Lord","year":"2001","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00302751","article-title":"The carcinogenic action of aristolochic acid in rats","volume":"51","author":"Mengs","year":"1982","journal-title":"Arch. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00293699","article-title":"Tumor induction in mice following exposure to aristolochic acid","volume":"61","author":"Mengs","year":"1988","journal-title":"Arch. Toxicol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/gei007","article-title":"Tumour induction in rats following exposure to short-term high dose aristolochic acid I","volume":"20","author":"Cui","year":"2005","journal-title":"Mutagenesis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00731.x","article-title":"Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy?","volume":"59","author":"Cosyns","year":"2001","journal-title":"Kidney Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.11.015","article-title":"Late Onset of Bladder Urothelial Carcinoma after Kidney Transplantation for End-Stage Aristolochic Acid Nephropathy: A Case Series With 15-Year Follow-up","volume":"51","author":"Lemy","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-158-6-201303190-00006","article-title":"The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy","volume":"158","author":"Gokmen","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000346180","article-title":"Development of a Chronic Kidney Disease Model in C57BL\/6 Mice with Relevance to Human Pathology","volume":"33","author":"Huang","year":"2013","journal-title":"Nephron Extra"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice","volume":"56","author":"Sato","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","article-title":"Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure","volume":"18","author":"Nortier","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.111.180984","article-title":"Physiological and molecular characterization of aristolochic acid transport by the kidney","volume":"338","author":"Dickman","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1523-1755.2005.00277.x","article-title":"Structure activity relationships of aristolochic acid analogues: Toxicity in cultured renal epithelial cells","volume":"67","author":"Balachandran","year":"2005","journal-title":"Kidney Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1124\/dmd.107.014688","article-title":"Selective toxicity of aristolochic acids I and II","volume":"35","author":"Shibutani","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/00498258709044197","article-title":"Studies on the metabolism of aristolochic acids I and II","volume":"17","author":"Krumbiegel","year":"1987","journal-title":"Xenobiotica"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/dmd.106.013979","article-title":"Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats","volume":"35","author":"Chan","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2014.05.004","article-title":"Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: Evidence for DNA repair by nucleotide-excision repair mechanisms","volume":"766\u2013767","author":"Leung","year":"2014","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/acs.chemrestox.5b00021","article-title":"Quantification of aristolochic acid-RNA adducts in the urine of aristolochic acid-treated rats by liquid chromatography-tandem mass spectrometry","volume":"28","author":"Leung","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/toxsci\/kfr138","article-title":"Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity","volume":"122","author":"Chen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchromb.2010.11.035","article-title":"A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry","volume":"879","author":"Guo","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1254\/jphs.09339SC","article-title":"Interactions of human organic anion transporters with aristolochic acids","volume":"196","author":"Babu","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","volume":"2","author":"Hagos","year":"2010","journal-title":"Toxins (Basel)"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/ajprenal.00439.2004","article-title":"Molecular physiology of renal organic anion transporters","volume":"290","author":"Sekine","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The Organic Anion Transporter (OAT) Family: A Systems Biology Perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Otani, N., Ouchi, M., Hayashi, K., Jutabha, P., and Anzai, N. (2016). Roles of organic anion transporters (OATs) in renal proximal tubules and their localization. Anat. Sci. Int.","DOI":"10.1007\/s12565-016-0369-3"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tox.2009.07.014","article-title":"Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy","volume":"264","author":"Bakhiya","year":"2009","journal-title":"Toxicology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/mol.109.056564","article-title":"Toward a systems level understanding of organic anion and other multispecific drug transporters: A remote sensing and signaling hypothesis","volume":"76","author":"Ahn","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_93","unstructured":"Anzai, N., and Endou, H. (2008). Renal drug transporters and nephrotoxicity. Life Sci., 447\u2013452."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug\u2013drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/mp100418u","article-title":"Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I","volume":"8","author":"Xue","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0960327111424302","article-title":"Organic anion transporter 1 (OAT1) involved in renal cell transport of aristolochic acid I","volume":"31","author":"Zeng","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ki.2012.264","article-title":"Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy","volume":"82","author":"Baudoux","year":"2012","journal-title":"Kidney Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.dnarep.2016.05.027","article-title":"Mutational signature of aristolochic acid: Clue to the recognition of a global disease","volume":"44","author":"Rosenquist","year":"2016","journal-title":"DNA Repair (Amst.)"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mrrev.2007.07.003","article-title":"Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy","volume":"658","author":"Frei","year":"2008","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5507\/bp.2009.001","article-title":"The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: Urgent questions and difficult answers","volume":"153","author":"Stiborova","year":"2009","journal-title":"Biomed. Pap."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.3390\/ijms150610271","article-title":"Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches","volume":"15","author":"Frei","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/tx200259y","article-title":"Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: Studies in Cyp1a1(\u2212\/\u2212), Cyp1a2(\u2212\/\u2212), and Cyp1a1\/1a2(\u2212\/\u2212) mice","volume":"24","author":"Arlt","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2174\/1389200211314060006","article-title":"Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer","volume":"14","author":"Frei","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Milichovk\u00fd, J., B\u00e1rta, F., Schmeiser, H., Arlt, V., Frei, E., Stiborov\u00e1, M., and Mart\u00ednek, V. (2016). Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020213"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ijc.28681","article-title":"Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy","volume":"135","author":"Schmeiser","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1039\/C5TX00052A","article-title":"New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid","volume":"4","author":"Yun","year":"2015","journal-title":"Toxicol. Res. (Camb.)"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/tx500423m","article-title":"Comparison of DNA and RNA Adduct Formation: Significantly Higher Levels of RNA than DNA Modifications in the Internal Organs of Aristolochic Acid-Dosed Rats","volume":"28","author":"Leung","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/ndt\/gfi042","article-title":"Early proximal tubule injury in experimental aristolochic acid nephropathy: Functional and histological studies","volume":"20","author":"Lebeau","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1113\/EP085333","article-title":"Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: An old friend with new assets","volume":"101","author":"Jadot","year":"2016","journal-title":"Exp. Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/ndt\/gfn140","article-title":"Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy","volume":"23","author":"Pozdzik","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.ki.5002714","article-title":"Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation","volume":"73","author":"Pozdzik","year":"2008","journal-title":"Kidney Int."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0272-6386(12)80186-7","article-title":"Acute interstitial nephritis following use of tung shueh pills","volume":"24","author":"Diamond","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Miller","year":"2012","journal-title":"Kidney Int."},{"key":"ref_115","first-page":"5464","article-title":"Aristolochic Acid Activates ras Genes in Rat Tumors at Deoxyadenosine Residues","volume":"50","author":"Schmeiser","year":"1990","journal-title":"Cancer Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e18.1","DOI":"10.1053\/j.ajkd.2003.11.024","article-title":"DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy","volume":"43","author":"Lord","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrrev.2013.02.003","article-title":"Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid","volume":"753","author":"Hollstein","year":"2013","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2009.01.005","article-title":"p53 mutations as fingerprints for aristolochic acid\u2014An environmental carcinogen in endemic (Balkan) nephropathy","volume":"663","author":"Slade","year":"2009","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"197ra102","DOI":"10.1126\/scitranslmed.3006200","article-title":"Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing","volume":"5","author":"Hoang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ijc.26077","article-title":"TP53 Mutational signature for aristolochic acid: An environmental carcinogen","volume":"129","author":"Moriya","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Aydin, S., Dekairelle, A.-F., Ambroise, J., Durant, J.-F., Heusterspreute, M., Cosyns, Y.G.J.-P., and Gala, J.-L. (2014). Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106301"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.tiv.2011.01.016","article-title":"Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1\/2 activation in human cells","volume":"25","author":"Yu","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00204-014-1249-z","article-title":"Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation","volume":"89","author":"Romanov","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.3892\/mmr.2015.4167","article-title":"Vitamin C attenuates the toxic effect of aristolochic acid on renal tubular cells via decreasing oxidative stress mediated cell death pathways","volume":"12","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fct.2015.11.020","article-title":"New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity","volume":"87","author":"Bunel","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbrc.2012.06.049","article-title":"Aristolochic acid-induced accumulation of methylglyoxal and N-(carboxymethyl)lysine: An important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy","volume":"423","author":"Li","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lfs.2014.07.034","article-title":"Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity","volume":"114","author":"Huang","year":"2014","journal-title":"Life Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/ndt\/gfg440","article-title":"Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity","volume":"18","author":"Okada","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s10495-006-0289-0","article-title":"Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells","volume":"11","author":"Hsin","year":"2006","journal-title":"Apoptosis"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2007.03.029","article-title":"Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid","volume":"222","author":"Qi","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10157-003-0229-z","article-title":"The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids","volume":"7","author":"Liu","year":"2003","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1681\/ASN.2008111133","article-title":"Activation of p53 promotes renal injury in acute aristolochic acid nephropathy","volume":"21","author":"Zhou","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Shi, M., Ma, L., Zhou, L., and Fu, P. (2016). Renal Protective Effects of 17\u03b2-Estradiol on Mice with Acute Aristolochic Acid Nephropathy. Molecules, 21.","DOI":"10.3390\/molecules21101391"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2004.00905.x","article-title":"The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids","volume":"66","author":"Debelle","year":"2004","journal-title":"Kidney Int."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2559.2010.03509.x","article-title":"Aristolochic acid nephropathy revisited: A place for innate and adaptive immunity?","volume":"56","author":"Pozdzik","year":"2010","journal-title":"Histopathology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trsl.2008.05.002","article-title":"Ischemic injury underlies the pathogenesis of aristolochic acid-induced acute kidney injury","volume":"152","author":"Wen","year":"2008","journal-title":"Transl. Res."},{"key":"ref_137","first-page":"1095","article-title":"Renal failure and urinary tract carcinoma secondary to the intake of certain Chinese herbal medicines","volume":"18","author":"Vanherweghem","year":"2002","journal-title":"Med. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000094778","article-title":"Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy","volume":"26","author":"Sun","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","article-title":"Acute Kidney Injury","volume":"67","author":"Zuk","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1113\/EP085545","article-title":"NO clue to pathogenesis of aristolochic acid nephropathy","volume":"101","author":"Gewin","year":"2016","journal-title":"Exp. Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/10799890903078465","article-title":"TGF-\u03b2 1\/Smads signaling stimulates renal interstitial fibrosis in experimental AAN","volume":"29","author":"Li","year":"2009","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10799890802176741","article-title":"TGF-\u03b21\/Smad7 Signaling Stimulates Renal Tubulointerstitial Fibrosis Induced by AAI","volume":"28","author":"Wang","year":"2008","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"F1006","DOI":"10.1152\/ajprenal.00675.2009","article-title":"Mechanism of chronic aristolochic acid nephropathy: Role of Smad3","volume":"298","author":"Zhou","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.18632\/oncotarget.3718","article-title":"Smad7 protects against chronic aristolochic acid nephropathy in mice","volume":"6","author":"Dai","year":"2015","journal-title":"Oncotarget"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jat.3116","article-title":"Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity","volume":"35","author":"Antoine","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1096\/fj.201500105R","article-title":"Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair","volume":"30","author":"Samarakoon","year":"2016","journal-title":"FASEB J."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Pozdzik, A.A., Giordano, L., Li, G., Antoine, M.-H., Quellard, N., Godet, J., de Prez, E., Husson, C., Decl\u00e8ves, A.-E., and Arlt, V.M. (2016). Blocking TGF-\u03b2 Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFR\u03b2+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157288"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.18632\/oncotarget.7460","article-title":"Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice","volume":"7","author":"Dai","year":"2016","journal-title":"Oncotarget"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:27:15Z","timestamp":1760207235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/2\/297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,29]]},"references-count":150,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"alternative-id":["ijms18020297"],"URL":"https:\/\/doi.org\/10.3390\/ijms18020297","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,29]]}}}